Clinical trial
Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of…
NCT00411190 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00411190 |
|---|---|
| Title | Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin |
| Official title | A Study to Evaluate the Potential for Pharmacokinetic Interaction Between SB 462795 and SSRIs in Healthy Subjects [3A] |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Relacatib, Acetaminophen, Ibuprofen, Atorvastatin |
| Enrollment | 32 |
| Start date | Oct 19, 2006 |
| Primary completion | Dec 15, 2006 |
| Completion | Dec 15, 2006 |
| First posted | Dec 13, 2006 |
| Last update posted | Oct 4, 2017 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: